Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses

There is increasing evidence that the risk of SARS-CoV-2 infection among vaccinated individuals is variant-specific, suggesting that protective immunity against SARS-CoV-2 may differ by variant. We enrolled vaccinated (n = 39) and unvaccinated (n = 11) individuals with acute, symptomatic SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Seaman, Michael S., Siedner, Mark J., Boucau, Julie, Lavine, Christy L., Ghantous, Fadi, Liew, May Y., Mathews, Josh, Singh, Arshdeep, Marino, Caitlin, Regan, James, Uddin, Rockib, Choudhary, Manish C., Flynn, James P., Chen, Geoffrey, Stuckwisch, Ashley M., Lipiner, Taryn, Kittilson, Autumn, Melberg, Meghan, Gilbert, Rebecca F., Reynolds, Zahra, Iyer, Surabhi L., Chamberlin, Grace C., Vyas, Tammy D., Vyas, Jatin M., Goldberg, Marcia B., Luban, Jeremy, Li, Jonathan Z., Barczak, Amy K., Lemieux, Jacob E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902886/
https://www.ncbi.nlm.nih.gov/pubmed/35262094
http://dx.doi.org/10.1101/2022.03.02.22271731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902886/
https://www.ncbi.nlm.nih.gov/pubmed/35262094
http://dx.doi.org/10.1101/2022.03.02.22271731

Ejemplares similares